These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4156356)

  • 1. In vitro activity of kitasamycin against gram-positive cocci.
    Balducci Y; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):516-9. PubMed ID: 4156356
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the antibacterial activity of rifampicin and other antibiotics.
    McCabe WR; Lorian V
    Am J Med Sci; 1968 Oct; 256(4):255-65. PubMed ID: 4387027
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.
    Marks MI
    Can Med Assoc J; 1975 Jan; 112(2):170-3. PubMed ID: 234287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephaloridine and cephalothin comparative in vitro evaluation.
    Perkins RL; Saslaw S; Hackett J
    Am J Med Sci; 1967 Mar; 253(3):293-9. PubMed ID: 4381476
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.
    Barry AL; Fuchs PC; Brown SD
    J Antimicrob Chemother; 1997 Jul; 40(1):139-40. PubMed ID: 9249220
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
    Benson CA; Segreti J; Beaudette FE; Hines DW; Goodman LJ; Kaplan RL; Trenholme GM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):328-30. PubMed ID: 2952063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of pneumococci to nine antibiotics.
    Kislak JW; Razavi LM; Daly AK; Finland M
    Am J Med Sci; 1965 Sep; 250(3):261-8. PubMed ID: 4378532
    [No Abstract]   [Full Text] [Related]  

  • 8. Penicillins and cephalosporins from isothiazolylacetic acids.
    Raap R; Micetich RG
    J Med Chem; 1968 Jan; 11(1):70-3. PubMed ID: 4384130
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K; Reisberg BE; Weinstein L
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract]   [Full Text] [Related]  

  • 10. Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
    Digranes A; Salveson A; Dibb WL
    Acta Pathol Microbiol Immunol Scand B; 1986 Apr; 94(2):85-8. PubMed ID: 3728027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
    Ferraro AL; Mortensen JE; Blecker DL; Phengvath C
    Adv Exp Med Biol; 1995; 390():119-21. PubMed ID: 8718607
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
    Westerman EL; Williams TW; Moreland N
    Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
    Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M
    Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
    Shadomy S; Tipple M; Paxton L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Flamm RK; Rhomberg PR; Sader HS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of antibiotic therapy.
    Wilkinson PM
    Br J Anaesth; 1976 Jan; 48(1):25-30. PubMed ID: 1252306
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tolerance of group A streptococci to the bactericidal effect of various antibiotics].
    Givental' NI; Krasil'nikova OA; Bogdanova LF; Vorob'eva LS; Labinskaia AS
    Antibiotiki; 1984 Dec; 29(12):917-21. PubMed ID: 6098218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.